Therapeutic Expertise

BioPier is a leading biostatistics and programming provider with recognition as a trusted partner. We've been awarded contracts for important studies in Rare Disease, Oncology, and GI, with a focus on late-phase studies. With a strong reputation for high-quality results, we've served as primary provider for a major pharmaceutical company, the #1 rare disease company, and a preferred vendor for a top pharmaceutical company. Our expertise helps drive pivotal studies in oncology, gastroenterology, and hematology.

Oncology

• Leukemia (ALL, AML, CML, etc)
• Multiple Myeloma (MM)
• Lymphoma
• Myelodysplastic Syndrome (MDS)
• Systemic Mastocytosis (SM)
• Lung Cancer (NSCLC)
• Gastrointestinal Stromal Tumors

Gastroenterology

• Eosinophilic Esophagitis
• Inflammatory Bowel Disease (IBD)
• Ulcerative Colitis and Crohn's Disease
• Liver Disease

Rare Genetic Disease

• Hereditary Angioedema (HAE)
• Hunter Syndrome
• Metachromatic Leukodystrophy (MLD)
• Gaucher Disease
• Fabry Disease
• Studies overlap with other therapeutic areas like SM, HAE

Hematology

• Thrombotic Thrombocytopenic Purpura (TTP)
• Hemophilia, von Willebrand disease (VWD)
• Rare Disorder of Mast Cells

Anti-Infectives

• Antiviral - CMV

Vaccine

• Influenza
• Dengue

CNS and Psychiatry

• Schizophrenia
• ADHD

Immunology

• Graft Versus Host Disease (GVHD)
• Studies overlap with other therapeutic areas like Immunodeficiency (HAE), Vaccines (Dengue, Influenza), Inflammation (IBD), and oncology (SM)